Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Nanocarrier Co Ltd | 3NQ | 16. mai 2024 | 0.75 | -0.67 |
NetScientific plc | NTK1 | 16. mai 2024 | 0.68 | 0.00 |
Newron Pharmaceuticals Spa. | NP5 | 16. mai 2024 | 10.48 | -1.50 |
Nuformix plc | 1RT | 16. mai 2024 | 0.00 | 0.00 |
Ocumension Therapeutics | 5DG | 16. mai 2024 | 0.80 | -0.63 |
Oncimmune Holdings plc | OCY | 16. mai 2024 | 0.22 | -3.54 |
Oncoarendi Therapeutics SA | 1B1 | 16. mai 2024 | 3.37 | -4.27 |
Oncotherpapy Science Inc | 30O | 16. mai 2024 | 0.07 | -7.69 |
Open Orphan plc | CRO | 16. mai 2024 | 0.30 | -1.31 |
Opthea Limited | UKJ | 16. mai 2024 | 0.40 | 0.00 |
OptiBiotix Health plc | OB3 | 16. mai 2024 | 0.20 | -1.96 |
Oric Pharmaceuticals, Inc. | 4TZ | 16. mai 2024 | 8.35 | -3.47 |
Oxford BioDynamics plc | LMQ | 16. mai 2024 | 0.05 | -0.98 |
Oxford Biomedica | OXOA | 16. mai 2024 | 3.72 | -0.53 |
Pharmaron Beijing Co Ltd | 17Q1 | 16. mai 2024 | 1.23 | +0.82 |
Pharmaust Ltd. | ECQ | 16. mai 2024 | 0.08 | -18.93 |
Philogen S.p.a. | 78Q | 16. mai 2024 | 17.05 | 0.00 |
Physiomics | RVW1 | 16. mai 2024 | 0.01 | +30.77 |
Polynovo Limited | MFJ | 16. mai 2024 | 1.31 | +1.55 |
Poseida Therapeutics, Inc. | 2RZ | 16. mai 2024 | 3.13 | +15.86 |
Pure Biologics S A | PQB | 16. mai 2024 | 1.52 | 0.00 |
PureTech Health Plc | 0VQ | 16. mai 2024 | 2.58 | +1.57 |
Quantum Genomics | 2QG | 16. mai 2024 | 0.12 | +0.50 |
RECCE PHARMACEUTICALS Ordinary Fully Paid (Australia) | R9Q | 16. mai 2024 | 0.34 | -2.29 |
Redx Pharma Plc | 0RX | 16. mai 2024 | 0.17 | 0.00 |
RemeGen Co. Ltd. | REG | 16. mai 2024 | 3.64 | +3.41 |
ReproCELL Incorporated | 6RC | 16. mai 2024 | 0.57 | -1.71 |
Ryvu Therapeutics S.A. | 9Y4 | 16. mai 2024 | 12.24 | +3.03 |
Sareum Holdings Plc | RYH0 | 16. mai 2024 | 0.43 | -5.29 |
Scancell Hldgs Plc | SCP | 16. mai 2024 | 0.10 | +16.36 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.